An interventional study of Telemedicine Consultation and Face-to-face Consultation in Respiratory Tract Infections, sponsored by Hospital Israelita Albert Einstein. Completed at 1 site in Brazil. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2021-08-31.
Sponsored by Hospital Israelita Albert Einstein · Not applicable, Interventional, and Diagnostic
This is a randomized study that sought to analyze the diagnostic accuracy of the telemedicine consultation of patients suspected of respiratory tract infections during COVID-19 pandemic in comparison with the face-to-face evaluation at the emergency department.
Unicentric, prospective and randomized study performed between September and November 2020 with adult patients who sought care at emergency department. The inclusion criterion was the exhibition of any tract respiratory symptom. Patients older than 65 years, with chronic heart or lung diseases or immunosuppressed were excluded. Eligible patients were randomized 1:1 for a brief telemedicine consultation, blinded to subsequent face-to-face evaluation or direct face-to-face evaluation.
6,687 studies on the registry are indexed under Infections; 807 are open to participants now.
This study's enrollment of 98 is below the median of 120 across 4,201 interventional studies indexed under Infections.
Browse Infections studies →Hospital Israelita Albert Einstein is the lead sponsor of 143 studies on the registry; 32 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
We included adults (≥18 years of age) who had at least one acute symptom compatible with Respiratory Tract Infection (sore throat, nasal obstruction, coryza, new or growing cough, sputum, hoarseness, dyspnea) with or without symptoms related to the infection (fever ≥ 38oC, chills, sweating, myalgia) who have undergone telemedicine consultation before face-to-face evaluation
Other: Telemedicine Consultation · Other: Face-to-face Consultation
We included adults (≥18 years of age) who had at least one acute symptom compatible with Respiratory Tract Infection (sore throat, nasal obstruction, coryza, new or growing cough, sputum, hoarseness, dyspnea) with or without symptoms related to the infection (fever ≥ 38oC, chills, sweating, myalgia) who have undergone only face-to-face evaluation
Other: Face-to-face Consultation
Brief telemedicine consultation, blinded to subsequent face-to-face evaluation.
Direct face-to-face evaluation (without telemedicine consultation before).
Number of final evaluation ICD 10-code diagnosis.
All institutional Emergency Department or Telemedicine assessments involve filling out the final diagnosis on an International Classification of Diseases (ICD-10)-code basis in the electronic medical record before discharge to home or admission. For aggregation of most prevalent RTI with similar pathophysiologic characteristics, three diagnostic groups were defined, based on ICD 10 codes: RTI, including COVID-19 (B34.2, B34.9, B97.2, J00, J04, J06, J11, J20, J30, J39, U07.1); PT - Acute Pharyngotonsillitis (J02-J03.9) and AS - Acute Sinusitis (J01-J01.9).
Time frame: up to 10 months
Time of medical care
Comparison of time (minutes) of medical care between telemedicine and face-to-face consultation.
Time frame: up to 10 months
Rate of indication for complementary exams
Comparison of rate (percentage) of indication for complementary exams between telemedicine and face-to-face consultation.
Time frame: up to 10 months
Type of requested exams
Comparison of type of requested exams (porcentage) between telemedicine and face-to-face consultation.
Time frame: up to 10 months
Type of Medical prescription
Comparison of type of medical prescription after completion of the service between telemedicine and face-to-face consultation
Time frame: up to 10 months
Type of proposed destination after completion of the service
Comparison of proposed destination (percentage of discharge or hospitalization) after completion of the service between telemedicine and face-to-face consultation.
Time frame: up to 10 months
Plan to share: No
This study is completed, as verified in Mar 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hospital Israelita Albert Einstein